Lisata Therapeutics (LSTA)
NASDAQ:LSTA
Holding LSTA?
Track your performance easily

Lisata Therapeutics (LSTA) Financial Statements

1,028 Followers

Lisata Therapeutics Financial Overview

Lisata Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.563; its P/E ratio is -1.12; Lisata Therapeutics is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.04M$ -6.60M-$ -5.96M$ -6.36M
EBITDA$ -4.85M$ -6.55M-$ -5.92M$ -6.57M
Net Income Common Stockholders$ -5.04M$ -5.40M$ -5.37M$ -5.26M$ -4.03M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.26M$ 43.35M$ 50.53M$ 54.39M$ 57.63M
Total Assets$ 42.57M$ 48.24M$ 54.69M$ 58.09M$ 62.37M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -38.26M$ -43.35M$ -50.53M$ -54.39M$ -57.63M
Total Liabilities$ 4.58M$ 5.50M$ 6.80M$ 5.38M$ 4.65M
Stockholders Equity$ 38.25M$ 43.00M$ 48.15M$ 52.96M$ 57.97M
Cash Flow-
Free Cash Flow$ -5.28M$ -7.03M$ -4.07M$ -3.58M$ -4.18M
Operating Cash Flow$ -5.28M$ -7.03M$ -4.07M$ -3.58M$ -4.18M
Investing Cash Flow$ 11.71M$ 6.44M$ -5.71M$ 12.25M$ -725.00K
Financing Cash Flow$ 32.00K$ -142.00K$ 24.00K$ -6.00K$ 452.00K
Currency in USD

Lisata Therapeutics Earnings and Revenue History

Lisata Therapeutics Debt to Assets

Lisata Therapeutics Cash Flow

Lisata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis